Physical comorbidities in patients with severe mental disorders: a brief narrative review on current challenges and practical implications for professionals.

A paradox of the modern world is represented by the increasing rate of comorbidities, although the life expectancy is increasing worldwide, the number of disease-free years is not improving consequently. Physical comorbidities are often overlooked in people with severe mental disorders, although this problem needs to be adequately managed since it is associated with a worse quality of life and a poorer personal and social functioning. In this paper, we aim to: 1) carry out a narrative review of the recent literature in order to provide an update on the prevalence and incidence of the most frequent comorbid physical disorders in people with severe mental disorders; 2) highlight the most important difficulties in managing comorbidities in people with severe mental disorders in ordinary clinical care; 3) discuss possible solutions to overcome those difficulties, particularly through the role of education and scientific associations.

[1]  M. Olfson,et al.  National trends in metabolic risk of psychiatric inpatients in the United States during the atypical antipsychotic era , 2022, Schizophrenia Research.

[2]  S. Rullo,et al.  Using sport-based interventions for people with severe mental disorders: results from the European EASMH study , 2022, International review of psychiatry.

[3]  G. Lorenzo,et al.  Improving physical activity and diet in patients with severe mental disorders: Results from the LIFESTYLE multicentric, real-world randomized controlled trial , 2022, Psychiatry Research.

[4]  A. T. Gomes,et al.  Prevalence and Factors Associated with Metabolic Syndrome in Patients at a Psychosocial Care Center: A Cross-Sectional Study , 2022, International journal of environmental research and public health.

[5]  A. Rossi,et al.  The Complex Interplay Between Physical Activity and Recovery Styles in Patients With Severe Mental Disorders in a Real-World Multicentric Study , 2022, Frontiers in Psychiatry.

[6]  K. Iburg,et al.  Mortality Associated With Mental Disorders and Comorbid General Medical Conditions , 2022, JAMA psychiatry.

[7]  Y. M. Mok,et al.  Association of cardiovascular metabolic risk factor measurements with psychiatric readmission among in-hospital patients with severe mental illness: a retrospective study , 2022, BMC Psychiatry.

[8]  N. Sartorius,et al.  Mortality gap and physical comorbidity of people with severe mental disorders: the public health scandal , 2021, Annals of General Psychiatry.

[9]  A. Roberts,et al.  Investigating the association between physical health comorbidities and disability in individuals with severe mental illness , 2021, European Psychiatry.

[10]  K. Koly,et al.  Prevalence of Overweight and Obesity in People With Severe Mental Illness: Systematic Review and Meta-Analysis , 2021, Frontiers in Endocrinology.

[11]  QuanQiu Wang,et al.  Increased risk for COVID‐19 breakthrough infection in fully vaccinated patients with substance use disorders in the United States between December 2020 and August 2021 , 2021, World psychiatry : official journal of the World Psychiatric Association.

[12]  David A. Baron,et al.  The Lifestyle Psychiatry project of the WPA Section on Medicine, Psychiatry and Primary Care , 2021, World psychiatry : official journal of the World Psychiatric Association.

[13]  Dan J Stein,et al.  The 2021‐2024 Work Plan of WPA Collaborating Centres , 2021, World psychiatry : official journal of the World Psychiatric Association.

[14]  L. Grassi,et al.  Psychiatric care in oncology and palliative medicine: new challenges and future perspectives , 2021, World psychiatry : official journal of the World Psychiatric Association.

[15]  L. Giuliani ICD‐11‐related educational activities , 2021, World psychiatry : official journal of the World Psychiatric Association.

[16]  L. McCracken Cognitive behavioral therapy, process‐based approaches, and evolution in the context of physical health , 2021, World psychiatry : official journal of the World Psychiatric Association.

[17]  N. Sartorius,et al.  Integration of mental health comorbidity in medical specialty programs in 20 countries , 2021, International journal of psychiatry in medicine.

[18]  L. Vedovelli,et al.  Over-specialization versus synergy in neuroscience: professionals’ integration is more than the sum of its parts , 2021, Neural regeneration research.

[19]  G. Sherwood Patient safety: sharing new evidence to confront a global crisis , 2021, Journal of research in nursing : JRN.

[20]  M. Subramaniam,et al.  Comorbid physical illnesses in adult outpatients with psychotic disorders: risk factors, psychological functioning, and quality of life outcomes , 2021, Social Psychiatry and Psychiatric Epidemiology.

[21]  A. Fagiolini,et al.  Identification and management of cardiometabolic risk in subjects with schizophrenia spectrum disorders: A Delphi expert consensus study , 2021, European Psychiatry.

[22]  S. Djurovic,et al.  Polygenic overlap and shared genetic loci between loneliness, severe mental disorders, and cardiovascular disease risk factors suggest shared molecular mechanisms , 2021, Translational Psychiatry.

[23]  S. Jensen,et al.  Cardiovascular disease in patients with severe mental illness , 2020, Nature Reviews Cardiology.

[24]  H. Whiteford,et al.  Nature and prevalence of combinations of mental disorders and their association with excess mortality in a population‐based cohort study , 2020, World psychiatry : official journal of the World Psychiatric Association.

[25]  R. Kallivayalil Strengthening the functioning of WPA through its Secretariat , 2020, World psychiatry : official journal of the World Psychiatric Association.

[26]  T. Schulze WPA Scientific Sections: a strengthened backbone for the 2020‐2023 triennium , 2020, World psychiatry : official journal of the World Psychiatric Association.

[27]  H. Herrman Report on the WPA Action Plan at the end of the triennium 2017‐2020 , 2020, World psychiatry : official journal of the World Psychiatric Association.

[28]  M. Slade,et al.  Rethinking the concept of insight , 2020, World psychiatry : official journal of the World Psychiatric Association.

[29]  V. Menon Brain networks and cognitive impairment in psychiatric disorders , 2020, World psychiatry : official journal of the World Psychiatric Association.

[30]  A. Carvalho,et al.  A meta‐review of “lifestyle psychiatry”: the role of exercise, smoking, diet and sleep in the prevention and treatment of mental disorders , 2020, World psychiatry : official journal of the World Psychiatric Association.

[31]  M. Horvitz-Lennon,et al.  Providing Health Physicals and/or Health Monitoring Services in Mental Health Clinics: Impact on Laboratory Screening and Monitoring for High Risk Populations , 2020, Administration and Policy in Mental Health and Mental Health Services Research.

[32]  R. Ng WPA educational initiatives: where are we after three years? , 2020, World psychiatry : official journal of the World Psychiatric Association.

[33]  C. Correll,et al.  Safety of 80 antidepressants, antipsychotics, anti‐attention‐deficit/hyperactivity medications and mood stabilizers in children and adolescents with psychiatric disorders: a large scale systematic meta‐review of 78 adverse effects , 2020, World psychiatry : official journal of the World Psychiatric Association.

[34]  H. Herrman The practice of psychiatry in health care and sustainable development: progress on the WPA Action Plan 2017‐2020 , 2020, World psychiatry : official journal of the World Psychiatric Association.

[35]  J. Gallinat,et al.  Neurocognitive deficits in schizophrenia are likely to be less severe and less related to the disorder than previously thought , 2020, World psychiatry : official journal of the World Psychiatric Association.

[36]  G. Ewald,et al.  Comorbid Conditions and Health-Related Quality of Life in Ambulatory Heart Failure Patients , 2020, Circulation. Heart failure.

[37]  T. Schulze The WPA Education, Science, Publication, and Research Initiative (ESPRI): jumpstarting scientific projects in low‐ and middle‐income countries , 2020, World psychiatry : official journal of the World Psychiatric Association.

[38]  A. Tanskanen,et al.  20‐year follow‐up study of physical morbidity and mortality in relationship to antipsychotic treatment in a nationwide cohort of 62,250 patients with schizophrenia (FIN20) , 2020, World psychiatry : official journal of the World Psychiatric Association.

[39]  B. Mcewen The untapped power of allostasis promoted by healthy lifestyles , 2020, World psychiatry : official journal of the World Psychiatric Association.

[40]  G. N. Norén,et al.  Pneumonia may be more frequent and have more fatal outcomes with clozapine than with other second‐generation antipsychotics , 2020, World psychiatry : official journal of the World Psychiatric Association.

[41]  Jacqueline L Johnson,et al.  Metformin add‐on vs. antipsychotic switch vs. continued antipsychotic treatment plus healthy lifestyle education in overweight or obese youth with severe mental illness: results from the IMPACT trial , 2020, World psychiatry : official journal of the World Psychiatric Association.

[42]  R. Kallivayalil The WPA website: newer user‐friendly functions , 2020, World psychiatry : official journal of the World Psychiatric Association.

[43]  S. Lofgren,et al.  Burden of Depression in Outpatient HIV-Infected adults in Sub-Saharan Africa; Systematic Review and Meta-analysis , 2019, AIDS and Behavior.

[44]  M. Pompili,et al.  Editorial: Reducing the Mortality Gap in People With Severe Mental Disorders: The Role of Lifestyle Psychosocial Interventions , 2019, Front. Psychiatry.

[45]  F. Pacitti,et al.  A Randomized Controlled Trial on the Efficacy of a Psychosocial Behavioral Intervention to Improve the Lifestyle of Patients With Severe Mental Disorders: Study Protocol , 2018, Front. Psychiatry.

[46]  K. Mulligan,et al.  Management of type 2 diabetes mellitus in people with severe mental illness: an online cross-sectional survey of healthcare professionals , 2018, BMJ Open.

[47]  J. Torgerson,et al.  Access to primary and specialized somatic health care for persons with severe mental illness: a qualitative study of perceived barriers and facilitators in Swedish health care , 2018, BMC Family Practice.

[48]  M. Page,et al.  Mapping of global scientific research in comorbidity and multimorbidity: A cross-sectional analysis , 2018, PloS one.

[49]  S. Asthana,et al.  Collaborative action for person-centred coordinated care (P3C): an approach to support the development of a comprehensive system-wide solution to fragmented care , 2017, Health Research Policy and Systems.

[50]  F. Burkle,et al.  The Enduring Health Challenges of Afghan Immigrants and Refugees in Iran: A Systematic Review , 2017, PLoS currents.

[51]  M. Pompili,et al.  Improving physical health of patients with severe mental disorders: a critical review of lifestyle psychosocial interventions , 2017, Expert review of neurotherapeutics.

[52]  A. Carvalho,et al.  Physical multimorbidity and psychosis: comprehensive cross sectional analysis including 242,952 people across 48 low- and middle-income countries , 2016, BMC Medicine.

[53]  S. Glew,et al.  Closing the gap between physical and mental health training. , 2016, The British journal of general practice : the journal of the Royal College of General Practitioners.

[54]  C. Violán,et al.  Cardiovascular risk assessment in patients with a severe mental illness: a systematic review and meta-analysis , 2016, BMC Psychiatry.

[55]  S. Gilbody,et al.  Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness: a systematic review and meta-analysis , 2016, The lancet. Psychiatry.

[56]  Caroline A. Baan,et al.  The impact of comorbid chronic conditions on quality of life in type 2 diabetes patients , 2015, Quality of Life Research.

[57]  D. Fitzgerald,et al.  Interdisciplinary collaboration in action: tracking the signal, tracing the noise , 2015, Palgrave Communications.

[58]  I. Kloszewska,et al.  Levels of triglycerides, cholesterol, LDL, HDL and glucose in patients with schizophrenia, unipolar depression and bipolar disorder. , 2015, Diabetes & metabolic syndrome.

[59]  D. Vancampfort,et al.  Physical activity and sedentary behaviour in outpatients with schizophrenia: A systematic review and meta-analysis , 2013 .

[60]  A. Fiorillo,et al.  Who cares for it? How to provide psychosocial interventions in the community , 2013, The International journal of social psychiatry.

[61]  J. Sundquist,et al.  Comorbidities and mortality in bipolar disorder: a Swedish national cohort study. , 2013, JAMA psychiatry.

[62]  A. Yang,et al.  Incidence and outcome of newly-diagnosed tuberculosis in schizophrenics: a 12-year, nationwide, retrospective longitudinal study , 2013, BMC Infectious Diseases.

[63]  David E. Goodrich,et al.  Mental Health Collaborative Care and its Role in Primary Care Settings , 2013, Current Psychiatry Reports.

[64]  Norman Sartorious,et al.  Comorbidity of mental and physical diseases: a main challenge for medicine of the 21st century , 2013, Shanghai archives of psychiatry.

[65]  E. Crowe,et al.  Cancer-related mortality in people with mental illness. , 2013, JAMA psychiatry.

[66]  G. Thornicroft Physical health disparities and mental illness: the scandal of premature mortality , 2011, British Journal of Psychiatry.

[67]  S. Kisely,et al.  Inequalities in healthcare provision for people with severe mental illness , 2010, Journal of psychopharmacology.

[68]  M. Maj,et al.  Physical illness and schizophrenia: a review of the literature , 2007, Acta psychiatrica Scandinavica.

[69]  S. Tirupati,et al.  Obesity and Metabolic Syndrome in a Psychiatric Rehabilitation Service , 2007, The Australian and New Zealand journal of psychiatry.